UNA S RYAN
CIK 1255349 · President & CEO · last filed 2025-10-02
UNA S RYAN is a President & CEO who has filed 38 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for RNXT, was dated Oct 2, 2025. Across all open-market trades the lifetime net is +$49.4K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
38
$49.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNXT | Director | — | $0.84 | — | $0 | 6 | 2025-10-02 |
| QNCX | Director | — | $0.93 | — | $0 | 3 | 2025-06-06 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Director | 2,875 | $1.95 | $5.6K | $48.9K | 4 | 2022-06-09 |
| ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Director | 51,845 | — | — | $562 | 22 | 2017-05-11 |
| Celldex Therapeutics, Inc. (AVAND) Delisted | President & CEO | — | — | — | $0 | 1 | 2008-03-11 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-02 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2024-10-02 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2023-10-02 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2022-10-04 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-14 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2021-10-05 | RNXT | Grant (A) | — | $0 | EDGAR |